The NHS offers treatment to people with COVID-19 who are at the highest risk of becoming seriously ill.

Who can have COVID-19 treatment

You're eligible for COVID-19 treatment without being admitted to hospital if all the following apply:

• you're aged 12 or over
• you're at highest risk of getting seriously ill from COVID-19
• you have symptoms of COVID-19
• you have tested positive for COVID-19

Some treatments are also available through a national study to a wider group of people, including those aged 50 years old and over (or 18 years old and over with a health condition that puts them at increased risk of COVID-19).

Treatments for COVID-19

The treatments available for people at the highest risk of becoming seriously ill from COVID-19 are:

• nirmatrelvir plus ritonavir (Paxlovid)
• sotrovimab (Xevudy)
• remdesivir (Veklury)
• molnupiravir (Lagevrio)

Nirmatrelvir plus ritonavir, remdesivir and molnupiravir are antiviral medicines. Sotrovimab is known as a neutralising monoclonal antibody (nMAb). Sotrovimab is recommended if nirmatrelvir plus ritonavir (Paxlovid) is not suitable.

Some treatments come as capsules or tablets that you swallow. Others are given to you through a drip in your arm (infusion), usually in a hospital or local health centre.

These treatments can help some people manage their COVID-19 symptoms and reduce the risk of becoming seriously ill. You'll be told which treatment, if any, is most suitable for you.